AXL and neoplasm: In this study, we demonstrated targeting AXL as a synergistic treatment in combination with WIN55212-2 by a significant reduction in cellular viability, colony formation and 3D tumor spheres, along with induction of the apoptosis of HCT-8 colon cells.